POSC94 Cost-Effectiveness of Risdiplam Versus Nusinersen for Treating Patients with Spinal Muscular Atrophy Type 1 in China. - Hu, J; Sutherland, CS; Aponte Ribero, V; Zhu, L; Hou, X; Xia, Y; Tang, M; Jin, C; Kang, Q (Value in Health, 2022)